SFI
LXRX icon

Susquehanna Fundamental Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$89K Sell
42,424
-37,431
-47% -$104K ﹤0.01% 1462
2021
Q4 		$315K Sell
79,855
-14,367
-15% -$69.8K 0.01% 1104
2021
Q3 		$453K Buy
94,222
+78,422
+496% +$322K 0.01% 1254
2021
Q2 		$73K Buy
+15,800
New +$76.1K ﹤0.01% 1598

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's LXRX Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Lexicon Pharmaceuticals (LXRX) stake by 47% in Q1 2022, selling an estimated $104K and leaving 42,424 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Susquehanna Fundamental Investments first reported a position in LXRX in Q2 2021 and has held it in 4 quarters since. The position peaked at $453K in Q3 2021. 101 funds tracked by Wall St. Rank hold LXRX as of Q1 2022.

  • Susquehanna Fundamental Investments held 42,424 shares of Lexicon Pharmaceuticals worth $89K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 37,431 Lexicon Pharmaceuticals shares in Q1 2022, an estimated $104K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1462 holding.
  • Susquehanna Fundamental Investments first reported a position in Lexicon Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
  • Susquehanna Fundamental Investments's Lexicon Pharmaceuticals position peaked at $453K in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.